SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-020523
Filing Date
2022-07-28
Accepted
2022-07-28 16:30:41
Documents
13
Period of Report
2022-07-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38868
2 ex10-1.htm EX-10.1 64057
  Complete submission text file 0001493152-22-020523.txt   290682

Data Files

Seq Description Document Type Size
3 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mslp-20220722.xsd EX-101.SCH 2968
4 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mslp-20220722_lab.xml EX-101.LAB 34916
5 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mslp-20220722_pre.xml EX-101.PRE 22795
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3443
Mailing Address 4721 IRONTON STREET DENVER CO 80239
Business Address 4721 IRONTON STREET DENVER CO 80239 (800) 210-7369
MusclePharm Corp (Filer) CIK: 0001415684 (see all company filings)

IRS No.: 770664193 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53166 | Film No.: 221115625
SIC: 2834 Pharmaceutical Preparations